Table 1.

Demographics and clinical characteristics at presentation.

Case no.	Age (years)	Sex	Comorbidities	NIHSS score at presentation	Visual symptoms at presentation	IV-tPA administration	Time of onset to MT (minutes)
1	84	Male	None	9	None	No	226
2	68	Female	None	5	Right hemianopia and partial gaze palsy	No	Unknown
3	69	Female	DM, Hypertension, Hyperlipidemia	8	Right hemianopia	No	Unknown
4	88	Female	Hypertension	7	Right hemianopia	No	189
5	71	Female	Hypertension, Afib	24	Left quadrant hemianopia	No	85
6	70	Female	COPD	9	Right temporal field deficit	No	105
7	68	Female	DM, Hypertension, Hyperlipidemia, CAD	17	Right, partial hemianopia	No	1080
8	79	Male	Hypertension, Afib	5	Right-sided complete vision loss	No	390
9	76	Male	Afib	7	None	Yes	158
10	78	Male	None	24	None	Yes	115
11	63	Male	DM, Hypertension	1	Right upper quadrant hemianopia	Yes	283
12	88	Female	Hypertension, Afib, DVT, Hyperlipidemia	14	Left sided complete vision loss	No	Unknown
13	74	Female	Hypertension, Afib	3	Right sided complete vision loss	No	94
14	54	Male	None	11	Right hemianopia	No	197
15	58	Male	Afib	8	Left sided complete vision loss	Yes	205
16	80	Female	DM	4	None	Yes	Unknown
17	53	Male	Hyperlipidemia	3	None	Yes	Unknown
18	56	Female	Hyperlipidemia	10	None	Yes	Unknown
19	82	Female	Hypertension, Afib	25	None	Yes	Unknown
20	67	Male	DM, Hypertension, Hyperlipidemia	11	None	Yes	186
21	69	Female	Hypertension, Hyperlipidemia, CAD, COPD	22	None	Yes	Unknown

Afib: atrial fibrillation; CAD: coronary artery disease; COPD: chronic obstructive pulmonary disease; DM: diabetes mellitus; DVT: deep vein thrombosis; IV-tPA: intravenous tissue plasminogen activator; MT: mechanical thrombectomy; NIHSS: National Institutes of Health Stroke Scale; no.: number.